Clinical Trials for Elix

Zanzalintinib in Men With Aggressive Variant Prostate Cancer

A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)

Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study

Trial of XL092 in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis

Zanzalintinib for Advanced Urothelial Carcinoma Progressing After Prior Therapy

Study of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC

Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)

Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

Comparing 3D and 2D Views in Biportal Spine Surgery: A Pilot Simulation Study

Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma

Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue Sarcoma

Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases

Maintenance Zanzalintinib With Etoposide After HDCT in GCT

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC

A-TANGO Phase 2 Study

Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

PSMA PET Combined With MRI for the Detection of PCa

CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC

Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

Study of HX15001 in Adult Healthy Volunteers.

XL092 and Cemiplimab in BRAF WT Thyroid Cancer

Pharmacokinetics (PK) and Safety of Zanzalintinib in Participants With Moderate Hepatic Impairment (HI)

A Study of XB628 in Participants With Recurrent Advanced or Metastatic Solid Tumors

Acute Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)

XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study

89Zr-olaratumab Dosimetry in Participants With Soft Tissue Sarcoma

An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer

Study of XB010 in Subjects With Solid Tumors

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

LSD Treatment for Persons With Alcohol Use Disorder

Comparison of Computed Tomography Data With Routine Measurements Concerning Bone and Muscle Health of Aged Individuals

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System

PSMA PET Response Guided SabR in High Risk Pca

Rollover Study From EXG-US-01

Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)

SERUM VITAMIN B12 LEVELS IN PATIENTS WITH HEMORRHAGIC VS ISCHEMIC CEREBROVASCULAR EVENT.

A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain

Cabozantinib With Ifosfamide in Ewing's Sarcoma and Osteosarcoma